Covidien divests part of medical supplies unit
This article was originally published in The Gray Sheet
Executive Summary
Covidien will sell its European incontinence product business to a private French firm for undisclosed terms under a definitive agreement announced Feb. 19. Previously a part of Covidien's struggling medical supplies unit, the divested business had sales of $109 million in fiscal 2007. Last December, Covidien sold its diaper-making retail unit for $335 million (1"The Gray Sheet" Jan. 7, 2008, p. 20)
You may also be interested in...
Covidien Keeps Medical Supplies Unit On Watch List After Sale Of Diaper Biz
Diversified med-tech firm Covidien will continue evaluating potential divestitures following the sale of its diaper-making retail unit, according to the company
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.